H.C. Wainwright downgraded Celcuity (CELC) to Neutral from Buy with a price target of $94, up from $77. The shares look “priced for perfection,” the analyst tells investors in a research note. The firm says Celcuity shares have appreciated 608% year-to-date. At current levels, there is more downside risk than upside, contends H.C. Wainwright.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CELC:
- Celcuity’s Gedatolisib: A Promising Standard for 2L Breast Cancer Treatment
- Celcuity Inc. Earnings Call: Strong Progress Amid Challenges
- Celcuity price target raised to $108 from $96 at Craig-Hallum
- Celcuity price target raised to $115 from $68 at Stifel
- Celcuity’s Strategic Advances and Robust Financials Justify Buy Rating